Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERISCOPEII: Cytoreductive Surgery and HIPEC in Gastric Cancer with Peritoneal Dissemination
NCT03348150Phase 3Active, not recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Oct 2017
- Primary completion
- Sep 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, docetaxel in gastric cancer (GC), peritoneal carcinomatosis (PC), sponsored by Netherlands Cancer Institute. Started Oct 2017; status: active, not recruiting.
02
Drugs
oxaliplatindocetaxel
03
Conditions
gastric cancer (GC)peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on NCT03348150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03348150.